Please enable JS

ARTICLES & TESTIMONIALS

Advertising campaign led by ACS-CAN

Jul 08/50SN Staff/ Open Comments

Advertising ACS CAN plans to do starting January 17th on the proposed policy changes to Medicare Part D’s “Six Protected Classes”. I originally sent an email before the holidays about the advertising opportunity, and then emailed some groups again last Friday. Unfortunately my email last Friday was not sent to our entire partner list.

READ MORE

Patients’ Perspectives on Romosozumab

Jul 08/50SN Staff/ Open Comments

Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee Meeting; Public Hearing. Docket No. FDA-2018-N-4116 Oral Comments made by patient Judith Marple on behalf of the Global Healthy Living Foundation “Patients’ Perspectives on Romosozumab” January 16th, 2019 Disclosure: I have disclosures to make. The Global Healthy Living Foundation paid for my travel here today. […]

READ MORE

Oklahoma 1115 Medicaid Waiver

Jul 08/50SN Staff/ Open Comments

January 18, 2019 The Honorable Alex Azar Secretary U.S. Department of Health and Human Services 200 Independence Avenue, SW Washington, DC 20201 Re: SoonerCare Choice 1115(a) Demonstration Waiver Amendment Dear Secretary Azar: Thank you for the opportunity to submit comments on the SoonerCare Choice 1115(a) Demonstration Waiver Amendment. The undersigned organizations represent millions of individuals […]

READ MORE

Market Program Integrity

Jul 08/50SN Staff/ Open Comments

January 8, 2019 Submitted electronically via www.regulations.gov Honorable Alex AzarSecretaryDepartment of Health and Human Services 200 Independence Avenue, SWWashington, DC 20201 Re: Patient Protection and Affordable Care Act; Exchange Program Integrity (CMS-9922-P)Dear Secretary Azar: The 17undersigned organizations represent millions of patients and consumers facing serious, acute and chronichealth conditions across the country, including individualswho rely […]

READ MORE

Patients’ Perspectives on Febuxostat and the Importance of Education

Jul 08/50SN Staff/ Open Comments

Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement; Public Hearing Comments by the Global Healthy Living Foundation “Patients’ Perspectives on Febuxostat and the Importance of Education” January 11th , 2019 Disclosure: We have no disclosures to make regarding this comment. The Global Healthy Living Foundation […]

READ MORE